Asia Pacific Smart Inhalers Market Analysis, Size, and Share by 2027

The Asia Pacific smart inhalers market is expected to reach US$ 1,539.97 Mn in 2027 from US$ 186.63 Mn in 2018. The market is estimated to grow with a CAGR of 27.2% from 2019-2027.

The growth of the market is driven by the factors such as, growing geriatric population rising prevalence of COPD and asthma, along with rising awareness regarding the medical condition. However, the market is likely to get impacted due to risks associated with cyber threats limited knowledge regarding the use of smart inhalers.

With rapid urbanization there has been growth in various adverse factors that have led to the growth of respiratory diseases across the Asia Pacific. Some of the factors leading to growth in the number of asthma and COPD cases across the Asia Pacific are a rise in air pollution levels and increasing smoking habits.

The rise in air pollution levels has been a matter of rising concern in developed as well as developing economies. As per data published by the World Health Organization (WHO) released during May 2018, 9 out of 10 individuals are believed to breathe air containing high levels of pollutants. Data published by WHO reveals that approximately 7 million people die every year due to exposure to fine particles present in polluted air, which penetrate deep into the lungs and the cardiovascular system. This leads to various diseases such as lung cancer, pneumonia, chronic obstructive pulmonary diseases and respiratory infections, among others. In 2016 Among the 2.2 million air pollution-related deaths in Asia pacific region, 29% were due to heart disease, 27% stroke, 22% chronic obstructive pulmonary disease, 14% lung cancer and 8% pneumonia. Additionally increasing indirect effects of air pollution like growing climate change, because of transport is the fastest growing source of fossil-fuel emissions of carbon dioxide (CO2) which is a largest contributor of the climate change. In 2017 World Health Organization (WHO) held a member states consultation on addressing the health impact of air pollution in the western pacific region, and continues to take steps to improve the situation. Children living near roads with heavy-duty vehicle traffic have twice the risk of respiratory problems as those living near less congested streets. Hence, the rising levels of air pollution coupled is anticipated to drive the demand for smart inhalers market during the forecast period

In 2018, the inhalers segment held a largest market share of the smart inhalers market, by product. The inhalers is expected to dominate its market share in 2027 owing to the increasing mortality rate of asthma. The inhalers segment is also anticipated to witness the fastest growth rate during the forecast period, 2019 to 2027.

China is expected to lead the market in the Asia Pacific region because the growing prevalence of asthma and COPD Across the country. According to the recent report published in the Lancet, Approximately 9% of china’s adult population about to 100 million people are suffering with chronic obstructive pulmonary disease (COPD). Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the Asia Pacific region during the forecast period.

Rest of Asia Pacific Smart Inhalers Market Revenue and Forecasts to 2027 (US$ Mn)

ASIA PACIFIC SMART INHALERS – MARKET SEGMENTATION

By Product

• Inhalers
• Nebulizers

By Disorder

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)

By End User

• Home-care Settings
• Hospitals & Clinics

By Geography

• Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Company Profiles

• GlaxoSmithKline plc
• Adherium Ltd.
• Vectura Group plc
• Novartis AG
• Findair Sp. z o. o.
• Cohero Health
• Crux Product Design Ltd
• Teva Pharmaceuticals
• 3M
• Amiko Digital Health Limited

Asia Pacific Smart Inhalers Report Scope